vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Distribution Solutions Group, Inc. (DSGR). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $518.0M, roughly 1.4× Distribution Solutions Group, Inc.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs 1.2%, a 2.4% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 10.7%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 13.1%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
CLOV vs DSGR — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $749.2M | $518.0M |
| Net Profit | $27.3M | $6.5M |
| Gross Margin | — | 32.9% |
| Operating Margin | 3.6% | 4.6% |
| Net Margin | 3.6% | 1.2% |
| Revenue YoY | 62.0% | 10.7% |
| Net Profit YoY | — | -70.6% |
| EPS (diluted) | $0.05 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $749.2M | — | ||
| Q4 25 | $487.7M | — | ||
| Q3 25 | $496.6M | $518.0M | ||
| Q2 25 | $477.6M | $502.4M | ||
| Q1 25 | $462.3M | $478.0M | ||
| Q4 24 | $337.0M | $480.5M | ||
| Q3 24 | $331.0M | $468.0M | ||
| Q2 24 | $356.3M | $439.5M |
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-49.3M | — | ||
| Q3 25 | $-24.4M | $6.5M | ||
| Q2 25 | $-10.6M | $5.0M | ||
| Q1 25 | $-1.3M | $3.3M | ||
| Q4 24 | $-22.1M | $-25.9M | ||
| Q3 24 | $-9.2M | $21.9M | ||
| Q2 24 | $7.4M | $1.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 33.9% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | 33.3% | ||
| Q3 24 | 24.5% | 33.9% | ||
| Q2 24 | 30.3% | 34.5% |
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | 4.6% | ||
| Q2 25 | -2.2% | 5.3% | ||
| Q1 25 | -0.3% | 4.2% | ||
| Q4 24 | -6.4% | 4.2% | ||
| Q3 24 | -2.7% | 4.0% | ||
| Q2 24 | 2.0% | 3.2% |
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | 1.2% | ||
| Q2 25 | -2.2% | 1.0% | ||
| Q1 25 | -0.3% | 0.7% | ||
| Q4 24 | -6.6% | -5.4% | ||
| Q3 24 | -2.8% | 4.7% | ||
| Q2 24 | 2.1% | 0.4% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $0.14 | ||
| Q2 25 | — | $0.11 | ||
| Q1 25 | — | $0.07 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $0.46 | ||
| Q2 24 | — | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.6M | $69.2M |
| Total DebtLower is stronger | — | $665.5M |
| Stockholders' EquityBook value | $339.4M | $653.9M |
| Total Assets | $697.7M | $1.8B |
| Debt / EquityLower = less leverage | — | 1.02× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.6M | — | ||
| Q4 25 | $78.3M | — | ||
| Q3 25 | — | $69.2M | ||
| Q2 25 | — | $47.4M | ||
| Q1 25 | — | $65.4M | ||
| Q4 24 | $194.5M | $66.5M | ||
| Q3 24 | $288.0M | $61.3M | ||
| Q2 24 | $254.8M | $46.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $665.5M | ||
| Q2 25 | — | $675.0M | ||
| Q1 25 | — | $712.4M | ||
| Q4 24 | — | $693.9M | ||
| Q3 24 | — | $704.1M | ||
| Q2 24 | — | $573.7M |
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | — | ||
| Q3 25 | $340.9M | $653.9M | ||
| Q2 25 | $344.2M | $649.4M | ||
| Q1 25 | $336.1M | $636.7M | ||
| Q4 24 | $341.1M | $640.5M | ||
| Q3 24 | $342.2M | $680.8M | ||
| Q2 24 | $324.9M | $653.3M |
| Q1 26 | $697.7M | — | ||
| Q4 25 | $541.0M | — | ||
| Q3 25 | $559.7M | $1.8B | ||
| Q2 25 | $575.0M | $1.8B | ||
| Q1 25 | $583.7M | $1.8B | ||
| Q4 24 | $580.7M | $1.7B | ||
| Q3 24 | $653.0M | $1.8B | ||
| Q2 24 | $674.2M | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.02× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $38.4M |
| Free Cash FlowOCF − Capex | — | $32.9M |
| FCF MarginFCF / Revenue | — | 6.3% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $92.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-66.9M | — | ||
| Q3 25 | $12.1M | $38.4M | ||
| Q2 25 | $5.4M | $33.3M | ||
| Q1 25 | $-16.3M | $-4.8M | ||
| Q4 24 | $34.8M | $45.7M | ||
| Q3 24 | $50.0M | $-17.3M | ||
| Q2 24 | $44.8M | $21.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-69.0M | — | ||
| Q3 25 | $11.4M | $32.9M | ||
| Q2 25 | $4.8M | $28.7M | ||
| Q1 25 | $-16.5M | $-10.4M | ||
| Q4 24 | $33.3M | $41.1M | ||
| Q3 24 | $49.6M | $-20.5M | ||
| Q2 24 | $44.4M | $18.0M |
| Q1 26 | — | — | ||
| Q4 25 | -14.1% | — | ||
| Q3 25 | 2.3% | 6.3% | ||
| Q2 25 | 1.0% | 5.7% | ||
| Q1 25 | -3.6% | -2.2% | ||
| Q4 24 | 9.9% | 8.6% | ||
| Q3 24 | 15.0% | -4.4% | ||
| Q2 24 | 12.5% | 4.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | 1.1% | ||
| Q2 25 | 0.1% | 0.9% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.5% | 1.0% | ||
| Q3 24 | 0.1% | 0.7% | ||
| Q2 24 | 0.1% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 5.95× | ||
| Q2 25 | — | 6.66× | ||
| Q1 25 | — | -1.46× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.79× | ||
| Q2 24 | 6.04× | 11.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
